Serine-threonine kinases and transcription factors active in signal transduction are detected at high levels of phosphorylation during mitosis in preimplantation embryos and trophoblast stem cells by Liu, Jian et al.
Wayne State University
DigitalCommons@WayneState
Department of Obstetrics and Gynecology
Research Publications
C.S. Mott Center for Human Growth and
Development
1-1-2004
Serine-threonine kinases and transcription factors
active in signal transduction are detected at high
levels of phosphorylation during mitosis in
preimplantation embryos and trophoblast stem
cells
Jian Liu
Wayne State University
Elizabeth E. Puscheck
Wayne State University
Fangfei Wang
Wayne State University
Anna Trostinskaia
Wayne State University
Dusan Barisic
Wayne State University
This Article is brought to you for free and open access by the C.S. Mott Center for Human Growth and Development at
DigitalCommons@WayneState. It has been accepted for inclusion in Department of Obstetrics and Gynecology Research Publications by an
authorized administrator of DigitalCommons@WayneState.
Recommended Citation
Liu J, Puscheck EE, Wang F, Trostinskaia A, Barisic D, Maniere G, Wygle D, Zhong W, Rings EHHM, & Rappolee DA 2004 Serine-
threonine kinases and transcription factors active in signal transduction are detected at high levels of phosphorylation during mitosis
in preimplantation embryos and trophoblast stem cells. Reproduction 128 643-654. doi:10.1530/rep.1.00264
Available at: http://digitalcommons.wayne.edu/med_obgyn/7
See next page for additional authors
Authors
Jian Liu, Elizabeth E. Puscheck, Fangfei Wang, Anna Trostinskaia, Dusan Barisic, Gordon Maniere, Dana
Wygle, W Zhong, Edmond HHM Rings, and Daniel A. Rappolee
This article is available at DigitalCommons@WayneState: http://digitalcommons.wayne.edu/med_obgyn/7
REPRODUCTIONRESEA CH
Serine-threonine kinases and transcription factors active
in signal transduction are detected at high levels of
phosphorylation during mitosis in preimplantation
embryos and trophoblast stem cells
Jian Liu1, Elizabeth E Puscheck1, Fangfei Wang1, Anna Trostinskaia1, Dusan Barisic1,
Gordon Maniere1, Dana Wygle1, W Zhong2, Edmond H H M Rings5 and
Daniel A Rappolee1,2–4
1C S Mott Center for Human Growth and Development, Department of Obstetrics and Gynecology,
Hutzel Hospital, Wayne State University School of Medicine, 2Department of Anatomy and Cell Biology,
Wayne State University School of Medicine, 3Karmanos Cancer Institute, Wayne State University School of
Medicine and 4Insitute for Environmental Health Science, Wayne State University School of Medicine, Detroit,
Michigan 48201, USA and 5Department of Pediatrics, Center for Liver, Digestive and Metabolic Diseases,
Academic Hospital Groningen, Groningen, The Netherlands
Correspondence should be addressed to Daniel A Rappolee, C S Mott Center for Human Growth and Development,
Wayne State University School of Medicine, 275 East Hancock, Detroit, Michigan 48201, USA; Email:
drappole@med.wayne.edu
Abstract
Serine-threonine kinases and transcription factors play important roles in the G1-S phase progression of the cell cycle.
Assays that use quantitative fluorescence by immunocytochemical means, or that measure band strength during Western blot
analysis, may have confused interpretations if the intention is to measure G1-S phase commitment of a small subpopulation of
phosphorylated proteins, when a larger conversion of the same population of proteins can occur during late G2 and M phases.
In mouse trophoblast stem cells (TSC), a human placental cell line (HTR), and/or mouse preimplantation embryos, 8/19 ser-
ine-threonine and tyrosine kinases, 3/8 transcription factors, and 8/14 phospho substrate and miscellaneous proteins were
phosphorylated at higher levels in M phase than in interphase. Most phosphoproteins appeared to associate with the spindle
complex during M phase, but one (p38MAPK) associated with the spindle pole and five (Cdx2, MEK1, 2, p27, and RSK1)
associated with the DNA. Phosphorylation was detected throughout apparent metaphase, anaphase and telophase for some
proteins, or for only one of these segments for others. The phosphorylation was from 2.1- to 6.2-fold higher during M phase
compared with interphase. These data suggest that, when planning and interpreting quantitative data and perturbation
experiments, consideration must be given to the role of serine-threonine kinases and transcription factors during decision
making in M phase as well as in G1-S phase.
Reproduction (2004) 128 643–654
Introduction
About 70% of fertilized human embryos are lost before
birth and the majority of these are lost at the time of
implantation in the uterus (Cross et al. 1994, Rappolee
1999). Since insufficient trophoblast proliferation is one of
the causes for loss of embryos, studies on trophoblast pro-
liferation will improve our understanding of the mechan-
isms underlying trophoblast growth and will help prevent
loss of embryos. Cell cycle progression is an important
part of cell proliferation. Serine-threonine kinases and
transcription factors play important roles in the progression
of the cell cycle (Roovers & Assoian 2000, Wilkinson &
Millar 2000, Rappolee 2003).
Many investigations on the roles of serine-threonine
kinases and transcription factors in mitosis have been car-
ried out in mammalian somatic cells, but little has been
done in preimplantation embryos. G1-S phase mitogenic
signal transduction is largely mediated by protein kinases;
examples include the Raf family, the mitogen activated
protein kinase (MAPK) family, the MAPK activating kinase
(MEK) family (Roovers & Assoian 2000, Wilkinson & Millar
2000) and transcription factors (e.g. MycC, fos; Sears &
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Nevins 2002). These transcription factors are downstream
of receptor tyrosine kinases (RTK) such as the fibroblast
growth factor (FGF) receptor family that mediate a necess-
ary mitogenic input into placental trophoblasts in the
preimplantation mouse embryo (Chai et al. 1998). During
this important period of decision-making, only small sub-
populations of protein kinases may be phosphorylated and
perform downstream functions. However, elevated (puta-
tively quantitative) conversion of populations of protein
kinases and transcription factors has been observed during
late G2, and throughout M phase in somatic cells (Willard
& Crouch 2001). Western blotting was used to determine
that some serine-threonine kinases were hyper-phosphory-
lated at M phase in the first two cell divisions of the mouse
embryo, but later preimplantation cell divisions showed no
hyper-phosphorylation (Iwamori et al. 2000).
The unique role of kinases during M phase is intriguing,
but not totally understood. It is likely that (1) there is a
change in the substrate range of kinases during M phase,
(2) the change must happen quickly due to the short dur-
ation of mitosis, and (3) a great number of M phase struc-
tural molecules (such as cytoskeletal tubulin) must be
phosphorylated. It is likely that nearly 100% of kinases of
one type may be converted for about 1 h of mitosis, but
less than 10% are converted for a few hours of G1 preced-
ing S phase (Whitmarsh & Davis 1999, 2000, Willard &
Crouch 2001). It is therefore important to know about the
kinases and transcription factors that are used by the pre-
implantation embryo for M phase, if correct interpret-
ations about function at the G1-S phase are to be made.
The purpose of this study was to investigate the
expression of activated phosphorylated serine-threonine
kinases and transcription factors during mitosis in mouse
preimplantation embryos and mouse and human tropho-
blast cells.
Materials and Methods
Reagents
The antibodies used were: 14-3-3 phospho substrate
(CS9601), Akt phospho SER473 (CS9271), Akt all forms
(SC5298), Akt1 phospho substrate (CS9611), ATF2 phospho
THR71 (CS9221), ATF2 all forms (CS9222), ATM phospho
ser1981 (CS4526), ATM/ATR phospho substrate (CS2851),
CDK2-phospho THR160 (CS2561), Elk-1 phospho SER383
(CS9186), Elk-1 all forms (SC355, CS9182), Ets2 (SC351),
FGFR1 phospho TYR766 (SC12935), FGFR1 all forms
(SC121), FRS2alpha phospho (CS3861), FRS2a all forms
(SC7131), GSK3a-phospho SER21/9 (CS9331), Jun-C phos-
pho SER63 (CS9261, SC7980-R), jun-C all forms (CS9262),
MAPK/ERK phospho THR202/TYR204 (CS9101), MAPK-
ERK all forms (CS9102), MAPK/ERK phospho
THR202/TYR204 (CS9106), MAPK-phospho THR202/
TYR204 (CS9106), MAPK-phospho THR183/TYR185
(M8159, Sigma Chemical Co., St Louis, MO, USA), MAPK
phospho (UBI 06-64206, Upstate Biotechnology Inc, Lake
Placid, NY, USA), MAPK5/ERK5 all forms (SC1284,
SC1285), ERK5 phospho Thr215 Tyr220 (CS3371), MEK1
all forms (SC219), MEK1 all forms (SC436), MEK1,2 all
forms (CS9122), MEK1,2 phospho SER217/SER221
(CS9121), MEK5 all forms (SC10795), MEK5 all forms
(SC9320), MSK-1 phospho SER360 (CS9594), MycB phos-
pho SER68 (SC16303R), myc C all forms rabbit (SC788),
MycC phospho THR58/SER62 (CS9401, SC8000R), p27
(SC528), p27KIP1 all forms (MS-256-P0, clone 16P07
Ab1), p27 phospho SER10 (SC12939R), p38MAPK all
forms (CS9212), p38MAPK phospho THR180/TYR182
(CS9211), p53 phospho SER15 (SC11764-R), p57
(SC8298), p57KIP2 all forms (MS-1062-P0, Ab6, clone
16P07), 3-phosphoinositide-dependent protein kinase
(PDK) phospho SER241 (CS3061), PDK phospho substrate
(CS2291, protein kinase (PK) A (PKA) phospho substrate
(CS9621), PKC phospho substrate (CS2261), Raf1 all forms
(SC7198), retinoblastoma (Rb) protein phospho SER795
(CS9301, SC7986R), ribosomal S6 kinase (RSK) 1 phospho
THR573 (RSK1) (CS9346), RSK1 all forms (SC231), RSK1
phospho SER380 (CS9341), 90RSK3 all forms (SC1431),
90RSK2 all forms (SC1430), RSK1 all forms (RSK1)
(CS9342), RSK1 phospho THR359/SER363 linker (RSK1)
(CS9344), RSK2 all forms (SC1430), RSK3 all forms
(SC1431), RSK2,1 phospho SER380 (SC11756), RSK3 phos-
pho (CS9345), stress activated protein kinase (SAPK)/JNK
all forms (CS9252), SAPK/JNK phospho THR183/TYR185
(CS9251), SOS1 all forms (SC10803, SC256), STAT1 phos-
pho TYR701 (CS9171), THR phospho (SC9381), TYR phos-
pho (PY350)(SC18182). All antibodies designated CS are
from Cell Signaling (Beverly, MA, USA), all antibodies
designated SC are from Santa Cruz Biotechnology (Santa
Cruz, CA, USA) and all antibodies designated MS are from
Lab Vision (Fremont, CA, USA).
Collection of mouse embryos
Standard techniques were used for obtaining mouse
embryos (Hogan et al. 2002). Female MF-1 mice (4–5
weeks old, Harlan Sprague Dawley, Indianapolis, IN,
USA) were injected intraperitoneally with 10 IU pregnant
mares’ serum gonadotropin (Sigma Chemical Co.), fol-
lowed by an injection of 7.5 IU human chorionic gonado-
tropin (Sigma Chemical Co.) 44–48 h later. After the
second injection, females were housed overnight with
C57BL/6J £ SJL/J F1 hybrid males (Jackson Laboratories,
Bar Harbor, ME, USA). Noon of the day following coitus
was considered day E0.5. For immunocytochemical (ICC)
analysis, embryos were obtained at the morula/early cavi-
tation blastocyst (E3.5), or at the 8-cell/compaction (E2.5)
stage; for reverse transcriptase-polymerase chain reaction
(RT-PCR), embryos were collected at the following stages:
unfertilized egg, 2-cell stage (E1.5), 8-cell/compaction
stage (E2.5) and morula-early blastocyst (E3.5) stage. The
animal use protocols were approved by the Wayne State
University Animal Investigation Committee.
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Placenta cell culture
Mouse TSC (Tanaka et al. 1998) and SV40 large T trans-
formed human trophoblast cells (HTR) (Graham et al.
1993) were cultured as described. In a few experiments,
TSC were cultured overnight with 0.5mg/ml of a commer-
cial colchicine analog, Karyomax Colcemid (Gibco/BRL
Gaithersburg, MD, USA), which blocked most cells in late
G2-prophase, not in metaphase.
Indirect immunocytochemistry and nuclear staining
For immunocytochemical analysis, TSC, HTR and E3.5
mouse embryos were fixed for 30 min in 2% fresh parafor-
maldehyde (pH 7.4) in phosphate-buffered saline (PBS),
quenched with 0.1 M glycine, and permeabilized for
10 min with 0.25% Triton X-100. The embryos were
stained with primary antibodies (diluted at 1:100 in PBS-
Tween with 10% fetal calf serum). The primary antibody
was followed by staining with biotinylated IgG (Vector
Labs, Burlingame, CA, USA). Proteins were visualized
with fluorescein isothiocyanate (FITC) coupled to strepta-
vidin (Vector Labs). Nuclear counterstaining was carried
out with Hoechst 33258 (10mg/ml). Photomicrography
was carried out with a Leica DM IRE2 epifluorescence
microscope with a Retiga 1350 Ex cooled charge coupled
device controlled electronically by SimplePCI AI module
software. Nearest or no neighbor deconvolution was per-
formed using the SimplePCI DNN module. Photographs
were analyzed using Photodex CPIC and C-Imaging
Simple PCI intensity analysis software (Compix Inc., Ima-
ging Systems, Cranberry Township, PA, USA) and for-
matted for presentation using Adobe Photoshop 6.0 (San
Jose, CA, USA). All fluorescence photos were handled and
analyzed in the same way. All experiments were repeated
at least twice with similar results.
Statistical analysis
The data in this study are representative of 2–3 indepen-
dent studies and are given as means^S.D. Statistical
significance of differences between different samples was
calculated by Student’s t-test (SPSS 10.0 and SISA website,
Uitenbroek 1997). P-values of less than 0.05 were con-
sidered significant.
Results
We investigated the high levels of phosphorylation of 19
serine-threonine and tyrosine kinases, 8 transcription
factors, and 14 other proteins or substrate groups during
mitosis (Fig. 1) in embryos, and in TSC and HTR cells.
In general, all threonine substrates are elevated at mitosis
(Fig. 2; note that figures including all controls for published
Figs 2–8 are provided as supplementary figures to the
online version of Reproduction (see http://reproduction-
online.org/content/vol128/issue5/index.shtml); supplemen-
tal Fig. 6), suggesting that serine-threonine kinase plays a
role in the regulation of mitosis. In embryos, TSC and HTR
it was found that among the individual serine-threonine
and tyrosine kinases studied, the following had a high
level of phosphorylation during mitosis: ATM (ataxia
telangiectasia mutants, note that 5 additional figures not
published are available at an on-line database; supplemen-
tal Fig. 1), MEK1, 2 and p27 (Fig. 3, supplemental Fig. 7),
RSK1, 3 (Figs 4 and 5, supplemental Figs 8 and 9), and
p38MAPK (Fig. 6, supplemental Fig. 10) (Table 1). Among
the transcription factors, we found a high mitotic phos-
phorylation of MycB (supplemental Fig. 2), MycC (Fig. 7,
supplemental Fig. 11), and Cdx (Fig. 8, supplemental
Fig. 12), in embryos, HTR, and TSC (3/8 phosphoprotein
transcription factors studied had elevated M phase
fluorescence) (Table 2).
The signaling enzymes and transcription factors studied
that are (or are not) highly phosphorylated at the M phases
are listed in Tables 1 and 2. The duration of their elevation
during mitosis is shown in Fig. 9. Mitosis typically lasts for
approximately one hour in somatic cells, and only a few
of the proteins studied had elevated phosphorylation
during all of mitosis. The cell cycles in both HTR and TSC
cells are close to 24 h (data not shown) and the preim-
plantation mouse embryo has a cell cycle at E3.5 of about
12 h (Pedersen 1987, Hogan et al. 2002). Confidence in
our ability to detect low frequency events such as meta-
phase, or other segments of the M phase, was based on a
survey of over 60 000 micrographs of embryos and pla-
cental cell lines. The morphology of mitotic cells was
clear in HTR and TSC. In embryos, it was more difficult to
detect classic metaphase plates although they were visible
Figure 1 Cell cycle diagram showing the short mitosis phase that
averages about 1 h and the longer S phase (DNA synthesis) that
averages about 8 h in somatic cells. Other cell cycle phases include
G1 (Gap1) when the decision to commit to S phase is made,
G2 (Gap2) when DNA repair is made after S phase and before
mitosis, M phase (mitosis), when cell and nuclear division occurs,
and GO phase, when a cell leaves the cell cycle and requires longer
(than G1 phase), or may completely loose the ability, to restart S
phase.
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(RSK1, Wang et al. 2004). However, the elevation in fluor-
escence intensity in a fraction of the cells in embryos
occurred only for those antibodies that also showed an
elevation of fluorescence intensity in obviously mitotic
HTR and TSC. In addition, the fraction of nuclei of TSC,
HTR, or embryos that had an elevated fluorescence inten-
sity was in the range of 1–4% (data not shown), corre-
sponding to the predicted fraction of unperturbed cells
that would be in M phase (or some segment of M-phase)
for 1 h or less/24 h cell cycle.
The majority of proteins studied had elevated phos-
phorylation only at M phase as indicated by obvious
morphologic criteria. It is interesting to note that a few
proteins with elevated fluorescence had additional non-M
phase fluorescence (Table 2; p53 phospho SER15, sup-
plemental Fig. 3) or the fluorescence was elevated during
cell cycle phases besides the M phase (Table 2; p57,
Ets2, supplemental Figs 4 and 5 respectively). This is in
agreement with previous studies that showed that p53
phospho SER15 is highest in cyclic somatic cells in early
G1 phase (Buschmann et al. 2000), and that p57 is acti-
vated during endocycle S phase and during the terminal
G1 phase of mitotic trophoblasts (Zhang et al. 1998,
Hattori et al. 2000).
The location of phosphoproteins elevated during mitosis
is tabulated in Table 3. The majority of phosphoproteins
were detected in the spindle complex, but p38MAPK
phospho was detected in the spindle pole, and Cdx2 was
localized with the DNA. This suggests, since many of
the phosphoproteins are in the MAPK pathway, that MAPK
may be involved with the regulation of the embryonic
spindle complex, consistent with a role for MEK-MAPK in
mitosis in Swiss 3T3 cells (Willard & Crouch 2001). Note
that the implied mitotic function of a given phosphopro-
tein may change quickly over developmental time, as we
could find no elevated MAPK phospho during mitosis in
preimplantation embryos using four anti-MAPK phospho
antibodies, although this has been reported in post-
implantation embryos (Corson et al. 2003). Although the
great majority of this study was undertaken in reviewing
large numbers of micrographs of unperturbed cultured
placental cells and embryos, we did perform one study
with a commercial colcemid analog, Karyomax. We
found that, as in some other cell types (manufacturer’s
notes), overnight incubation of TSC with Karyomax elev-
ated the fraction of cells with condensed, smaller, circular
nuclei that were putative late G2/prophase. Normally,
MEK1, 2 phospho was elevated and detected in cells in
metaphase or anaphase where it appeared to be in the
spindle complex, or in a very small fraction of cells with
condensed nuclei where phosphoprotein was detected as
spots on the DNA (Fig. 3A, B, C, supplemental Fig. 7).
The Karyomax protocol also elevated the fraction of cells
with elevated fluorescence for MEK1, 2 phospho (Fig. 3G,
H, I, supplemental Fig. 7) and p27 phospho (Fig. 3J, K, L,
supplemental Fig. 7). Interestingly, this treatment also
created similar 1-, 2-, and 4-spotted circular nuclei that
were correlated with TSC sheet dispersion and nuclear
size increase, suggesting that the differentiation state of
trophoblast cells might correlate with MEK1,2 and p27
expression around M phase. This brief study produced the
desired result of increasing the fraction of cells with elev-
ated phosphoprotein expression at or around M phase.
However, the lack of metaphase block in this cell type,
and the inability to associate localization of nuclear spots
with function in unperturbed cells, led us to discontinue
this avenue of M phase testing. It is interesting to note
that (1) possible co-localization of p27 and MEK1,2 might
suggest an enzyme substrate interaction, and (2) at a
very low frequency MEK1,2 nuclear spots were seen in
unperturbed TSC. Point number (2) suggests that the local-
ization in the DNA may not be an artifact of tubulin
Figure 2 Threonine (Thr) phospho is detected at elevated levels in TSC at mitosis. TSC were cultured, fixed, and developed by immunocyto-
chemical means for Thr phospho. (A, B, C) TSC stained with Thr phospho stain, Hoechst stain, and after merging respectively. TSC in apparent
metaphase with elevated expression localized in the apparent mitotic spindle are shown by an arrow in A and arrowheads in B and C. (D, E, F)
E3.5 embryos stained with Thr phospho stain, Hoechst stain, and after merging respectively. Arrow (in D) shows position of nucleus and arrow-
heads (in E, F) show nucleus.
646 J Liu and others
Reproduction (2004) 128 643–654 www.reproduction-online.org
depolymerization caused by Karyomax, but may reflect a
low frequency event in unperturbed cells. This suggests
that the proper colchicine derivative might be used in
studies of M phase function of phosphoproteins in TSC
and embryos.
To quantitate the elevation in fluorescence intensity at M
phase, we performed a comparison of the levels of inten-
sity of mitotic cells compared with interphase cells (Table
4). All phosphoproteins had a higher intensity at M phase
than in interphase cells, in the range of 1.5–5.6
(mean ¼ 2.8) for ratios of raw quantitated immunofluores-
cence to 2.0–6.2 (mean ¼ 3.8) for the same ratios after a
no-antibody background was subtracted from both the
means for the M phase (numerator) and interphase
(denominator). In baseline studies for each antibody, it was
shown that the fluorescence for each antibody was hgiher
than with no-antibody, non-immune serum, or for antibody
with co-addition of excess immunizing antigen (data not
shown). One weakness of the study is that the pictures
were taken by different individuals and they had a ten-
dency to shoot micrographs on the high or low intensity
range of the 0–255 units/pixel intensity range of the
Simple PCI software. The micrographs were taken to
emphasize the differences between interphase and M-
phase fluorescence. In baseline studies for each antibody,
it was shown that the fluorescence for each antibody was
Figure 3 MEK1, 2 phospho and p27 phospho proteins are detected at elevated levels in TSC and E3.5 embryos at mitosis. MEK1, 2 phospho pro-
teins are detected at elevated levels in TSC and E3.5 embryos at apparent prophase and anaphase mitosis. TSC were cultured, fixed, and devel-
oped by immunocytochemical means for MEK1, 2 phospho. (A, B, C) TSC stained with MEK1, 2 phospho stain, Hoechst stain, and after merging
respectively. TSC in apparent anaphase with elevated expression localized in the mitotic spindle are shown by the bottom arrow in A while the
top arrow shows a putative prophase cell MEK1, 2 phospho spots on the DNA. Corresponding arrowheads show nuclear position in B and C.
(D, E, F) E3.5 embryos stained with MEK1, 2 phospho stain, Hoechst stain, and after merging respectively. (G, H, I) Uniform nuclear spotting of
MEK1, 2 phospho in Karyomax-treated TSC corresponding to Hoechst stain, and after merging respectively. (J, K, L) Karyomax-treated TSC
stained with p27 phospho stain, Hoechst stain, and after merging respectively. Arrows and arrowheads in D–L show position of nuclei.
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www.reproduction-online.org Reproduction (2004) 128 643–654
higher than with no-antibody, non-immune serum, or for
antibody with co-addition of excess immunizing antigen
(data not shown). The high end of the fluorescence range is
not linear due to pixel saturation and so the ratios may be
an underestimate of the intensity of M-phase fluorescence
and the corresponding fractions of protein populations that
are phosphorylated.
Discussion
A little under half of serine-threonine kinases and tran-
scription factors have a high level of phosphorylation at M
phase. Although this is a small sample size, it seems likely
that these fractions may extend to yet-to-be tested tran-
scription factors and kinases.
Mitosis requires a large reorganization of the cellular
cytoskeleton. Microtubules are reorganized to form a
bipolar spindle; the chromosomes become condensed,
attach to the spindles at their kinetochores and are
segregated into two daughter cells. Reorganization of the
mitotic cytoskeleton requires a large, rapid surge of ser-
ine-threonine protein phosphorylation, controlling signal-
ing events that coordinate mitotic processes. Our data
(Fig. 2) are consistent with the increase in all threonine
phosphorylation substrates at M phase. An important trig-
ger of the phosphorylation surge is the cyclin-dependent
kinase (CDK), Cdc2. After CDK is activated, mitotic
Figure 4 RSK1 phospho is detected at elevated levels in TSC and E3.5 embryos at mitosis. TSC were cultured and E3.5 embryos were isolated
and fixed and developed by immunocytochemical means for RSK1 phospho. (A, B, C) TSC in apparent anaphase with elevated expression loca-
lized in the mitotic spindle. (D, E, F) Elevated expression of RSK1 phospho is detected in E3.5 embryos in mitotic cells, with condensed chromo-
somes and in apparent anaphase. Arrowheads (B, C, E, F) show nuclei and arrows (A, D) show position of nucleus.
Figure 5 RSK3 phospho is detected at elevated levels in TSC and E3.5 embryos at mitosis. TSC were cultured and E3.5 embryos were isolated
and fixed and developed by immunocytochemical means for RSK3 phospho. (A, B, C) TSC stained by RSK3 phospho stain, Hoechst stain, and
after merging respectively, showing TSC in telephase with elevated expression colocalized with the reforming cytoplasm. (D, E, F) E3.5 embryos
stained with RSK3 phospho stain, Hoechst stain, and after merging respectively, showing elevated expression in mitotic cells, with condensed
chromosomes, Arrows in A and D show positions of nuclei, and arrowheads in B, C, E, F show nuclei.
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serine/threonine kinases in three families - the polo
kinases, aurora kinases and the NIMA-related kinases
(Nrk) - govern mitosis (Piwnica-Worms 1996, O’Connell
et al. 2003). These mitosis-specific enzymes may also
control enzymes recruited from other pathways that func-
tion during interphase. For example, phosphatidylinositol-
3 kinase (PI3Kinase), 3-phosphoinositide-dependent pro-
tein kinase (PDK), Akt1 (Dangi et al. 2003), CDK2 (Doree
& Galas 1994), MycC (Niklinski et al. 2000), Raf1,
MEK1,2, MAPK1,2 and RSK1, 2, 3 (Willard & Crouch
2001) are involved with M phase in somatic cells, and in
G1-S phase signaling (Sears et al. 2000, Wilkinson &
Millar 2000, Rappolee 2003). The entire MAPK pathway
is detected in preimplantation mouse embryos (Wang
et al. 2004, Xie et al. 2004). Little work has been done on
the interaction of the MAPK pathway with the three mito-
sis-specific enzyme families during mitosis. But, during
meiosis, MAPK can be upstream of polo-like kinase in
starfish oocytes (Okano-Uchida et al. 2003), MAPK can
regulate NIMA-related kinases in mouse spermatogenesis
(Di Agostino et al. 2002), but MAPK pathway is appar-
ently independent of aurora kinases in frog oocytes
(Maton et al. 2003). This is the first report of high levels
of expression for these MAPK pathway phosphoproteins
in late preimplantation embryos and placental cells at M
phase. These data are consistent with a putative M phase
function of MAPK pathway enzymes in early placental
lineage cells.
It is important to keep these findings in mind when
planning experiments and interpreting data regarding
Figure 6 p38MAPK phospho proteins are detected at elevated levels in TSC and E3.5 embryos at mitosis. (A, B, C) TSC in metaphase with elev-
ated expression of p38MAPK phospho in spindle poles. (D, E, F) Elevated expression of p38MAPK phospho is detected in E3.5 embryos in a
mitotic cell, with condensed chromosomes. Arrowheads (B, C, E, F) show nuclei and arrows (A, D) show the position of the nuclei.
Figure 7 MycC phospho proteins are detected at elevated levels in TSC and E3.5 embryos at mitosis. (A, B, C) TSC in metaphase, anaphase, and
telophase with elevated expression of MycC phospho localized in the mitotic spinctle. (D, E, F) Elevated expression of MycC phospho is
detected in E3.5 embryos in mitotic cells, with condensed chromosomes. Arrowheads (B, C, E, F) show nuclei and arrows (A, D) show position
of the nuclei.
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G1-S phase decision making in the early embryo. If
measuring induction of interphase responses to growth
factors by kinases or transcription factors using quantitat-
ive immunofluorescence, elevated fluorescence in mitotic
cells (‘mitotic hotspots’) should be avoided. Alternatively,
attempts can be made to synchronize cell divisions in
order to avoid M phase. Similarly, if loss-of-function per-
turbations are performed, investigators should be alert for
M phase phenotypes. An additional consideration is that
alternative functions of the enzyme or transcription factor
besides those controlling G1-S phase progression may
also occur during G1-S phase.
The mitotic function of kinases changes during develop-
ment. It is suggested, for example, that MEK1, 2 function
is required for M phase completion as the MEK1, 2, 5
inhibitor, U0126, can block mitosis (Willard & Crouch
Figure 8 Cdx phospho proteins are detected at elevated levels in HTR and E3.5 embryos at mitosis. (A, B, C) HTR in metaphase and anaphase
with elevated expression of Cdx phospho localized with DNA. (D, E. F) Elevated expression of Cdx phospho is detected in E3.5 embryos in mitotic
cells, with condensed chromosomes. Note that these embryos are not at the same scale as in Figs 2–7. The arrow on top of A shows a cell at ana-
phase, the arrow at the botton of A shows a cell at metaphase. The arrows at D show positions of nuclei, arrowheads in B, C, E, F show nuclei.
Figure 9 Summary of temporal expression of
threonine-serine kinases and transcription factors
that are phosphorylated at high levels during
mitosis. Large grey boxes represent three M-phase
segments when fluorescence intensity is elevated in
normal cells, and smaller black rectangles show
additional effects in colchicine/Karyomax-treated
cells.
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2001). Therefore, MEK seems to be a dominant G1-S
phase kinase used at M phase, but MAPK seems not to be
as important in somatic cells (Harding et al. 2003) or in
mouse embryos during M phase of the first two cleavage
divisions (Iwamori et al. 2000). Our data are in agreement
with these reports. Like the 1- to 4-cell stage embryo (Iwa-
mori et al. 2000), MEK1, 2 participates in M phase later in
preimplantation development as shown by immunocyto-
chemical means. In contrast to the 1- to 4-cell stage
embryos, Raf1 is not highly phosphorylated during M
phase in later stage preimplantation embryos or in TSC
and HTR. Dissimilar to our data and that of Iwamori and
colleagues, MAPK phospho is elevated in post-implan-
tation embryos at M phase (Corson et al. 2003). It seems
that the embryo may use different sets of kinases at M
phase during different phases of development. Therefore,
an additional caution may be that the data presented here
may apply to preimplantation development, but each
researcher may have to re-examine the expression of these
kinases and transcription factors during each period of
embryonic development studied.
This study was based upon a large scan of proteins
and phosphoproteins using 153 antibodies and 49 phos-
pho-specific antibodies in ‘unperturbed’ embryos ex vivo,
and placental TSC and HTR cultured under normal pro-
liferation-promoting conditions. Approximately, 60 000
fluorescence micrographs were recorded, allowing low
frequency, short-duration events such as metaphase or
anaphase a good opportunity to be observed. Since the
preimplantation embryo is translucent and small (having
less than 100 cells through E3.5), it lends itself to immuno-
cytochemistry more than to Western blot analysis. In this
study, we focused on a mini-proteomics approach where
immunocytochemistry was performed in embryos and cell
lines. In other studies (Wang et al. 2004, Xie et al. 2004,
data not shown), Western blots were analyzed for TSC and
HTR, cell lines that represent about 75% of cells in the
E3.5 embryo, and the antibodies tested in TSC or embryos
are indicated in Tables 1 and 2. A weakness of this study is
that Western blots were not performed in the embryos
themselves. Such a study would be very prohibitive in
cost. A strength of this study is that 29 of the proteins
reported here had at least two antibodies that yielded simi-
lar results, and that all phosphoproteins, except p53, had
similar frequencies of cells with elevated phosphoprotein
fluorescence in TSC/HTR as in embryos. In the case of
p53, elevated p53 occurred during obvious M phase and
also during other apparent cell cycle phases. This made
these results difficult to interpret as HTR is transgenic for
SV40 large T antigens and this transforming may affect p53
stability and the dynamics of phosphorylation (Graham
et al. 1993, Meek 2002). In addition, TSC may partially
represent a period of placental lineage development
slightly after preimplantation development. All the anti-
bodies with no elevated phosphoprotein fluorescence in
TSC/HTR also had no elevated phosphoprotein fluor-
escence in embryos. The congruence of negative and posi-
tive findings for elevation of phosphoproteins at M phase
was complete for TSC/HTR compared with embryos
except for one phosphoprotein.
Table 1 Signaling enzymes that have elevated phosphorylation during mitosis: intermediary serine- threonine kinases signal transduction proteins.
Protein Antibody* Cell type M phase**
Akt1 phospho SC1618* HTR, TSC, embryo þ
Akt phospho SC5298 TSC þ
ATM phospho CS4526 HTR, embryo þ
MEK1,2 all forms CS9122* TSC, HTR, embryo þ
MEK1,2 phospho CS9121* TSC, HTR, embryo þ
MEK5 all forms SC10795* TSC, HTR, embryo þ
PDK phospho CS3061* HTR, embryo þ
RSK1 phospho CS9344* TSC, HTR, embryo þ
RSK3 phospho CS9345* TSC, HTR, embryo þ
p38MAPK all forms CS9212* TSC, HTR, embryo þ
p38MAPK phospho CS9211* TSC, HTR, embryo þ
CDK2 phospho CS2561* HTR, embryo 2
FGFR1 phospho SC12935 TSC, HTR, embryo 2
GSK3alpha phospho CS9331 HTR, embryo 2
MAPK1,2 phospho CS9101* TSC, HTR, embryo 2
MAPK1,2 phospho M8159* TSC, HTR, embryo 2
MAPK1,2 phospho CS9106* TSC, HTR, embryo 2
MAPK1,2 phospho UBI 06-624* TSC, HTR, embryo 2
ERK5, phospho CS3371* HTR, embryo 2
Raf1 phospho CS9421* TSC, HTR, embryo 2
Raf1 phospho SC7198* TSC, HTR, embryo 2
Raf1,2 phospho SC12358 HTR, embryo 2
SAPK phospho CS9251* TSC, HTR, embryo 2
SAPK all forms CS9251* TSC, HTR, embryo 2
* Western blots showed a single or major band of the correct size from lysates of TSC or HTR (Wang et al. 2004, Xie et al. 2004) (not shown).
** þ Signifies that elevated fluorescence intensity in apparent mitotic cells was detected, and 2signifies that elevated fluorescence intensity in
apparent mitotic cells was never detected.
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Table 2 Transcription factors and other proteins that have elevated phosphorylation during mitosis.
Protein Antibody Cell type M phase
Transcription factors
ATF2 phospho CS9221 HTR, TSC, embryo 2
Elk1 phospho CS9186 TSC, embryo 2
JunC phospho CS9261* HTR, TSC, embryo 2
STAT1 phospho CS9171 TSC, embryo 2
Ets2 all forms SC351* TSC, HTR, 2 (only putative S phase)*
Cdx2 phospho Rings et al.a HTR, embryo þ
MycB phospho SC16303* TSC, HTR, embryo þ
MycC phospho SC8000* TSC, HTR, embryo þ
Phospho-protein substrates (sub) and others
TYR phospho sub SC18182 TSC, embryo þ
THR phospho sub SC9381 TSC, embryo þ
Akt1 phospho sub CS9611 HTR, embryo þ
ATM phospho sub CS2851 HTR þ
PKA phospho sub CS9621 HTR þ
Rb phospho CS9301* TSC, HTR, embryo þ
Rb phospho SC7986R* TSC, HTR, embryo þ
PDK phospho sub CS2291 HTR þ
p53 phospho SC11764* HTR þ (þputative G1 phase)***
p57 all forms SC8298 TSC, HTR 2 (only S phase)**
p57KIP2 MS-1062-P0 TSC, HTR 2 (only S phase)**
p21 phospho SER146 SC12902R HTR, embryo 2
p21WAF1 MS-387-P0 HTR, embryo 2
p21WAF1 MS-387-P0 HTR, embryo 2
p27 phospho SC12939R HTR, embryo 2
p27KIP1 MS-256-P0 HTR, embryo 2
Estrogen R-a phospho CS2514 HTR, embryo 2
Estrogen R-a phospho CS2515 HTR, embryo 2
PKC phospho sub CS2261 HTR, embryo 2
14-3-3 sub CS9601 HTR, embryo 2
FRS2alpha phospho CS3861* HTR, embryo 2
* Western blots showed a single or major band of the correct size from lysates of TSC or HTR (not shown).
** Similar distribution in fraction of cells and morphogenetic identity of nuclei as observed previously for p57 as cells leave cytokinetic prolifer-
ation and enter endoreduplication in late G1 (Zhang et al. 1998, Hattori et al. 2000).
*** Similar distribution in fraction of cells and morphogenetic identity of nuclei as suggested for p53 phospho SER15 for largest activation during
G1 phase (Buschmann et al. 2000).
a (Rings et al. 2001).
Table 3 Cellular location of phosphorylated threonine-serine kinases and transcription factors at mitosis.
Protein Location at M phase
Serine-threonine protein kinases
Akt1 phospho Mitotic spindle colocalization
MEK1, 2 all forms Mitotic spindle colocalization at metaphase, 2 spots on DNA with colchicine at putative prophase*
MEK1, 2 phospho Mitotic spindle colocalization at metaphase, 2 spots on DNA with colchicine at putative prophase*
MEK5 all forms Mitotic spindle colocalization
RSK1 phospho Mitotic spindle colocalization, DNA
RSK3 phospho Mitotic spindle colocalization
p38MAPK all forms Mitotic spindle, pole
p38MAPK phospho Mitotic spindle, pole
Transcription factors
Cdx2 phospho Condensed DNA colocalization
MycB phospho Mitotic spindle colocalization
MycC phospho Mitotic spindle colocalization
Other proteins
TYR phospho sub Mitotic spindle
THR phospho sub Mitotic spindle, pole
ATM phospho sub Mitotic spindle
Akt1 phospho sub Mitotic spindle
p27 1–4 spots on DNA with colchicine; similar spots at very low frequency in unperturbed cells*
Rb phospho Mitotic spindle
* Note that these double spots also occur at very low frequencies in normal TSC, untreated by colchicine/Karyomax. This suggests that the spot-
ting is not an artifact of Karyomax, but a trapping of a low frequency event whose frequency is increased by Karyomax.
sub, substrate.
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Several proteins had a unique M phase localization.
Cdx2 is, like aurora-B kinase, a cell cycle M-phase
passenger (Higuchi & Uhlmann 2003) that moves from
centromeres to the spindle midzone during mitosis, func-
tioning throughout mitosis in chromosome condensation
and segregation (Adams et al. 2001).
p38MAPK was detected in the spindle poles.
p38MAPK is detected throughout preimplantation mouse
development (Zhong et al. 2004), and mediates mitosis
during early Xenopus cleavage divisions and is located
in the spindle pole (Takenaka et al. 1998). The majority
of phosphoproteins were observed in the putative spin-
dle complex.
In summary, this study shows that a little under half of
the signaling enzymes and transcription factors studied
had elevated levels of phosphorylation at M phase in
preimplantation mouse embryos and placental cell lines,
suggesting that caution must be used in interpreting
expression studies and cause-and-effect experiments
aimed at testing the role of these phosphoproteins during
G1 to S phase decision making. The results also suggest
that the studies primarily aimed at testing the role of these
phosphoproteins in early embryo/placental M phase
function would also be of interest.
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